Similar insulin secretory response to a gastric inhibitory polypeptide bolus injection at euglycemia in first-degree relatives of patients with type 2 diabetes and control subjects.

Medicin og biovidenskab

• Analysis of Variance 4%
• B-Lymphocytes 4%
• Body Weight 17%
• C-Peptide 42%
• Eating 4%
• Fasting 4%
• Gastric Inhibitory Polypeptide 100%
• Glucose 7%
• Glucose Tolerance Test 6%
• Healthy Volunteers 4%
• Hyperglycemia 5%
• Injections 39%
• Insulin 46%
• Insulin Secretion 18%
• Intravenous Administration 11%
• Intravenous Infusions 6%
• Intravenous Injections 5%
• Placebos 4%
• Type 2 Diabetes Mellitus 50%